Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 161 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact161 DOIs

Add abstracts to 123 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact123 DOIs

Add license metadata to 57 records

License metadata tells indexers and readers how each article may be reused.

Low impact57 DOIs

DOIs for this ISSN

Showing the top 5 of 946 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Delivery of Financial Navigation Services within National Ca… (10.1093/jncics/pkab033)	References ORCID License	129.93	53
2	Population Frequency of Serous Tubal Intraepithelial Carcino… (10.1093/jncics/pky061)	ORCID License	83.60	46
3	Determinants of Mammographic Breast Density by Race Among a… (10.1093/jncics/pkaa010)	References ORCID	80.10	39
4	Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role… (10.1093/jncics/pky052)	ORCID License	76.57	33
5	Exclusion of Male Patients in Breast Cancer Clinical Trials (10.1093/jncics/pky018)	Abstract ORCID	71.57	26
6	The Potential for Mammographic Breast Density Change as a Bi… (10.1093/jncics/pky072)	Abstract ORCID License	71.57	8
7	Change in Survival in Metastatic Breast Cancer with Treatmen… (10.1093/jncics/pky062)	ORCID	60.94	273
8	Extent of Exclusions for Chronic Conditions in Breast Cancer… (10.1093/jncics/pky059)	ORCID License	58.80	14
9	Corrigendum to “Contemporary Associations of Exclusive Cigar… (10.1093/jncics/pkz105)	Abstract References ORCID	58.36	5
10	Burden of Human Papillomavirus (HPV)-Related Cancers Attribu… (10.1093/jncics/pky045)	ORCID	56.97	189
11	Sedentary Behaviors, TV Viewing Time, and Risk of Young-Onse… (10.1093/jncics/pky073)	ORCID	55.82	170
12	Mortality for robotic- versus video-assisted lobectomy treat… (10.1093/jncics/pkaa028)	References ORCID	55.70	12
13	Cancer Treatment-Related Infertility: A Critical Review of t… (10.1093/jncics/pkz008)	ORCID	53.81	141
14	Evaluating the Effectiveness of Neoadjuvant Chemotherapy in… (10.1093/jncics/pkx004)	Abstract ORCID License	52.42	4
15	Trends in International Incidence of Pediatric Cancers in Ch… (10.1093/jncics/pkz007)	ORCID	51.33	112
16	The Current Understanding of the Endocrine Effects From Immu… (10.1093/jncics/pky021)	ORCID	50.84	107
17	A Systematic Review and Recommendation for Reporting of Surr… (10.1093/jncics/pkz002)	ORCID	48.86	89
18	Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with… (10.1093/jncics/pky043)	ORCID	47.85	81
19	Factors Associated With Health-Related Quality of Life Among… (10.1093/jncics/pkaa123)	License	47.71	80
20	Mismatch Repair Protein Loss as a Prognostic and Predictive… (10.1093/jncics/pky056)	ORCID	46.13	69
21	Racial and Ethnic Disparities Among Participants in US-Based… (10.1093/jncics/pkaa060)	ORCID	44.45	59
22	Prometastatic Molecular Profiles in Breast Tumors From Socia… (10.1093/jncics/pky029)	ORCID	42.47	49
23	Mutation Signatures Including APOBEC in Cancer Cell Lines (10.1093/jncics/pky002)	ORCID	41.80	46
24	White Blood Cell Count and Risk of Incident Lung Cancer in t… (10.1093/jncics/pkz102)	License	41.80	46
25	Oral Contraceptive Use and Breast Cancer Risk: Retrospective… (10.1093/jncics/pky023)	ORCID	41.09	43
26	The WISDOM Personalized Breast Cancer Screening Trial: Simul… (10.1093/jncics/pky067)	ORCID	41.09	43
27	Determinants of Mammographic Density Change (10.1093/jncics/pkz004)	ORCID	40.58	41
28	National Lung Cancer Screening Utilization Trends in the Vet… (10.1093/jncics/pkaa053)	License	40.32	40
29	Markers of Immune Activation and Inflammation, and Non-Hodgk… (10.1093/jncics/pky082)	ORCID	40.32	40
30	Breast Edema Following Breast-Conserving Surgery and Radioth… (10.1093/jncics/pkz011)	ORCID	40.32	40
31	Cancer Incidence and Multilevel Measures of Residential Econ… (10.1093/jncics/pky009)	ORCID	40.05	39
32	Association of the Insulinemic Potential of Diet and Lifesty… (10.1093/jncics/pky080)	ORCID	39.78	38
33	Methionine-Homocysteine Pathway in African-American Prostate… (10.1093/jncics/pkz019)	ORCID	39.49	37
34	Lung Cancer Mortality in the Lung Screening Study Feasibilit… (10.1093/jncics/pky042)	ORCID	39.21	36
35	Defining a Clinically Meaningful Benefit in Cancer Clinical… (10.1093/jncics/pky039)	Abstract ORCID	38.91	5
36	Development and Validation of a Risk Score for Febrile Neutr… (10.1093/jncics/pky053)	ORCID	38.91	35
37	Radiation Risks of Uterine Cancer in Atomic Bomb Survivors:… (10.1093/jncics/pky081)	ORCID	38.91	35
38	Temporal Trends in Mortality from Major Cancers by Education… (10.1093/jncics/pkz087)	References ORCID	38.91	5
39	“Still a Cancer Patient”—Associations of Cancer Identity Wit… (10.1093/jncics/pky031)	ORCID	38.60	34
40	The Landscape of Somatic Genetic Alterations in Breast Cance… (10.1093/jncics/pkz027)	ORCID	38.29	33
41	A Prognostic Gene Signature Expressed in Primary Cutaneous M… (10.1093/jncics/pky032)	ORCID	37.63	31
42	Multicenter Randomized Controlled Trial of Omega-3 Fatty Aci… (10.1093/jncics/pkz005)	ORCID	37.63	31
43	Impact of Self-Acupressure on Co-Occurring Symptoms in Cance… (10.1093/jncics/pky064)	ORCID	37.28	30
44	Low-Carbohydrate Diet Score and Macronutrient Intake in Rela… (10.1093/jncics/pky077)	ORCID	37.28	30
45	Delayed Colonoscopy Following a Positive Fecal Test Result a… (10.1093/jncics/pkz024)	ORCID	37.28	30
46	The Influence of Number and Timing of Pregnancies on Breast… (10.1093/jncics/pky078)	ORCID	36.56	28
47	Risk of Nonmelanoma Skin Cancer in Association With Use of H… (10.1093/jncics/pkab009)	License	36.18	27
48	Comparing Survival After Recurrent vs De Novo Stage IV Advan… (10.1093/jncics/pky024)	ORCID	36.18	27
49	Postdiagnosis Changes in Cigarette Smoking and Survival Foll… (10.1093/jncics/pkx001)	ORCID	35.78	26
50	Prospects for Minimal Residual Disease as a Surrogate Endpoi… (10.1093/jncics/pky070)	Abstract ORCID License	35.78	2